Drug Profile
Anti-interleukin-10 monoclonal antibody
Latest Information Update: 12 Nov 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Systemic lupus erythematosus
Most Recent Events
- 11 Oct 2000 Investigation in Systemic lupus erythematosus in Mexico (Unknown route)